帕金森病的流行病学
帕金森病的流行病学在时间、地理、种族、年龄和性别上呈现显著差异。国际上患病率已超出人口结构变化而上升,可能与其它竞争性死因减少有关;发病率是否上升尚不确定,尤其在女性及高质量数据缺乏的低收入与中等收入国家。该病病因涉及遗传与环境多因素,风险因素(如农药)和保护因素(如体力活动、吸烟倾向)均被推测起作用,但长前驱期使因果推断复杂化。
要点
- 国际上帕金森病患病率已超出人口结构变化而上升。
- 发病率是否上升尚不确定,女性及部分低收入与中等收入国家数据不足。
- 病因涉及遗传与环境多因素,风险与保护因素均被推测起作用。
核心结论
- 帕金森病流行病学在时间、地理、种族、年龄和性别上存在显著差异,国际上患病率已超出人口结构变化而上升。
- 病因涉及遗传与环境多因素,风险因素(如农药)与保护因素(如体力活动、吸烟倾向)均被推测起作用,但长前驱期使因果推断复杂化。
- 需要多管齐下的预防策略,涵盖基于人群的一级预防、高风险靶向二级预防及帕金森病修饰疗法三级预防。
研究设计与样本
- 本文为流行病学综述,未报告系统检索范围。
主要发现
- 国际上患病率已超出人口结构变化而上升,可能原因包括其它竞争性死因减少。
- 帕金森病在老年人和男性中更常见,多种环境因素被提出可解释此现象,包括暴露于神经毒性物质。
- 国家内不同种族间疾病风险存在差异,但这些差异可能反映医疗可及性不同。
- 发病率是否上升尚不确定,尤其在女性或高质量数据缺乏的许多低收入与中等收入国家。
- 风险因素(如农药)和保护因素(如体力活动、吸烟倾向)均被推测在帕金森病中起作用,但长前驱期使因果推断复杂化。
临床怎么用
- 在心血管疾病和部分癌症公共卫生策略建立后,帕金森病和痴呆等慢性神经退行性疾病正获得应有的更高优先级。
- 需要多管齐下的预防策略,涵盖基于人群的一级预防、高风险靶向二级预防及帕金森病修饰疗法三级预防。
- 未来需要国际协作,三角验证基础、应用和流行病学研究证据,以在全球层面增进对帕金森病的理解和预防。
局限性
- 女性或许多低收入与中等收入国家高质量数据缺乏,使发病率是否上升更不确定。
- 国家内种族间疾病风险差异可能反映医疗可及性不同。
- 长前驱期使风险因素与保护因素的因果推断复杂化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The epidemiology of Parkinson's disease shows marked variations in time, geography, ethnicity, age, and sex. Internationally, prevalence has increased over and above demographic changes. There are several potential reasons for this increase, including the decline in other competing causes of death. Whether incidence is increasing, especially in women or in many low-income and middle-income countries where there is a shortage of high-quality data, is less certain. Parkinson's disease is more common in older people and men, and a variety of environmental factors have been suggested to explain why, including exposure to neurotoxic agents. Within countries, there appear to be ethnic differences in disease risk, although these differences might reflect differential access to health care. The cause of Parkinson's disease is multifactorial, and involves genetic and environmental factors. Both risk factors (eg, pesticides) and protective factors (eg, physical activity and tendency to smoke) have been postulated to have a role in Parkinson's disease, although elucidating causality is complicated by the long prodromal period. Following the establishment of public health strategies to prevent cardiovascular diseases and some cancers, chronic neurodegenerative diseases such as Parkinson's disease and dementia are gaining a deserved higher priority. Multipronged prevention strategies are required that tackle population-based primary prevention, high-risk targeted secondary prevention, and Parkinson's disease-modifying therapies for tertiary prevention. Future international collaborations will be required to triangulate evidence from basic, applied, and epidemiological research, thereby enhancing the understanding and prevention of Parkinson's disease at a global level.
引用
- Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, et al. The epidemiology of Parkinson's disease. Lancet. 2024. PMID: 38245248. doi:10.1016/S0140-6736(23)01419-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。